San Francisco, California (PRWEB) February 17, 2016
QURE Healthcare is very pleased to announce the appointment of Mary Tran, M.S. as its Director of Clinical Programs. Ms. Tran is an internationally recognized healthcare strategist having worked with care providers, industry firms, public regulators and policy experts around the world to assist in delivering high-value and cost-effective medical care. As the Director of Clinical Programs, Mary will oversee study development and quality assurance across each of QURE’s focus areas: health care providers, life sciences and global health.
Mary will also play a lead role in building QURE’s Life Science capabilities with her deep experience advising life science firms in developing and implementing market access strategies (coverage, pricing and reimbursement) for an array of products across a number of clinical areas. Mary’s work serving as the nexus of coverage and reimbursement discussions among health technology assessment committees, payers and manufacturers will aid QURE in further demonstrating its value proposition to different types of life science companies.
“As we continue to prove the value of QURE’s CPV vignette tool for developing key clinical utility data for life science companies seeking coverage and reimbursement, Mary will provide important leadership along with our Vice President, Scott FitzSimons for expanding QURE’s reach to other types of diagnostic, device and pharmaceutical companies seeking to better understand the clinical utility of their products.” said Dr. John Peabody, QURE’s President and Founder. “Mary’s deep understanding of the regulatory environment, coupled with her strategic insights will be a valuable addition to projects with life science companies facing greater pressure to show value in an atmosphere of ever-changing regulatory priorities.”
“We live in an era of value where all healthcare entities must work together to provide high quality, cost-effective care. QURE’s unique tool aligns providers around evidence-based medicine and efficiently demonstrates product value to achieve both,” said Ms. Tran. “I am excited to be a part of QURE’s fast-growing team and to deliver its unique solution that is greatly needed in the market place.”
Ms. Tran comes most recently from New York where she held leadership positions in the MedTech Global Market Access group within Navigant Consulting’s Life Sciences practice, an international healthcare consultancy. Mary received her M.S. in International Affairs with a focus on International Business and Development from New York University, during which she interned with the United Nations Development Programme and held research positions abroad. In addition, Mary received a B.A. in English from the University of Michigan, where she also completed a pre-medical curriculum.
About QURE Healthcare
QURE Healthcare is a research and business strategy firm committed to improving the quality of clinical care. QURE uses its proprietary software technology, CPV® (Clinical Performance and Value) vignettes, to evaluate clinical practice and the cost-effectiveness of health care services at the level of individual physicians and other health care providers. CPV® vignettes are used in health systems in the US and over 30 countries worldwide. Core services include CPV® studies, health economic analyses, and physician-level data collection. The ease, validity and affordability of CPV® vignettes attract a wide array of clients: payers, hospital systems, life science firms, medical technology companies, medical licensing and education institutions as well as international health development organizations.